Cosmecoin Explained

Imagine this scenario.

Your child wants a nose job. They broke their nose in an accident when they were younger and it has bothered them since. You know that in getting this procedure, they will be much more confident.

But it’s a difficult knowing who to trust.

You’ve seen so many awful, botched cosmetic cases in the media. You don’t want your son to end up in a back room somewhere, with an unqualified practitioner attempting the procedure. Likewise, you don’t want his medical data or photos to become public property.

You definitely aren’t alone. These concerns are incredibly common in the Cosmetic Surgery and Medical Aesthetics industries. Approximately 50% of those who actively consider a procedure does not go through with it. [1]

So where do you go from here?

This is where Cosmecoin comes in.

What is Cosmecoin?

iConsult Software Ltd. has developed Cosmecoin. It is an upgrade to their existing, award-winning software, used within Cosmetic Surgery and Medical Aesthetic businesses globally. This system uses blockchain technology and smart contracts to create a reward-based ecosystem. The software aims to connect, record, protect and reward patients and practitioners alike.

Sounds confusing, doesn’t it? Let me break it down for you.

The Cosmecoin ecosystem can be split into two parts: the practitioner software and the patient portal.

The practitioner software (Clinic OS) provides aesthetic businesses with a market-leading CRM system to help manage the day-to-day running of their clinic. Clinic OS provides a digitalised and comprehensive consultation process, including treatment specific forms, which ensures that all important data is recorded fully and securely. Detailed records allow for clinic audits to be carried out quickly and easily, saving time and money. Once the appropriate information is collected, it is encrypted and placed on a cloud-based database, which ensures the secure and trustworthy storage of data.

The patient portal (Cosmecoin) combines a whole hoard of services in one app. It will provide consumers with an extensive database of practitioners, clinics and treatments. This comes with unbiased, genuine patient feedback, allowing individuals to make informed decisions before treatments. The Cosmecoin blog will supply consumers with up-to-date industry news and educational articles.

Patients have the choice to log in to the app to get easy access to their own medical data. This includes their treatment history, photos, consent forms, and aftercare information. The system also allows personal data to be securely transmitted between clinics if a patient chooses to receive different treatments in different practices. Treatment bookings and payment can be easily carried out through the app.

These two sections of the ecosystem are combined together by the Cosmecoin reward-token (COSX). Like a supermarket loyalty point, COSX tokens are allocated to patients, for practitioner feedback and platform engagement, and practitioners, for best practice behaviours. Within the patient portal on the Cosmecoin app, consumers will be able to view a digital ‘wallet’. This will detail the number of COSX reward-tokens they have and their token transaction history.

COSX reward-tokens can be redeemed for discounts on further treatments booked through the Cosmecoin app. Alternatively, consumers can head over to the ‘Cosmecoin shop’ within the app and use tokens to purchase (or part-purchase) aesthetic products (e.g. skincare, etc.).

In short, the Cosmecoin app and accompanying Clinic OS software will work together to provide the Cosmetic Surgery and Medical Aesthetics industries will an all-in-one ecosystem. This will provide solutions to industry problems and revolutionise aesthetics forever.

Lia Burnell

iConsult Community Manager


Neither this document nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment whatsoever in any jurisdiction. Any offer to acquire tokens will be made, and any investor should make its investment decision solely on the basis of the information that is contained in the information memorandum to be published by iConsult Software Ltd in due course in connection. Copies of the information memorandum will, following publication, be available at

These materials are not an offer of securities for sale in the United States. The securities to which these materials relate have not been registered under the US Securities Act of 1933, as amended (the “Securities Act”) or the securities laws of any state or jurisdiction of the United States. Accordingly, these securities may not be, sold, pledged, assigned, delivered or otherwise transferred, exercised or redeemed, at any time, within the United States or to, or for the account or benefit of, U.S. Persons. There will be no public offering of the securities in the United States.